Posts by Kristin M. D'Silva, MD
-
COVID-19 Patients with Rheumatic and Musculoskeletal Diseases at Substantial Risk of Poor Outcomes
Clinicians in the Division of Rheumatology, Allergy and Immunology found that for patients with rheumatic and musculoskeletal diseases who develop COVID-19, the risks of death and other severe outcomes have declined since early in the pandemic but remain considerable.
-
Case Series: COVID-19 Patients with Rheumatic Disease Can Develop SARS-CoV-2 Antibodies
Kristin M. D'Silva, MD, and Zachary S. Wallace, MD, MSc, of the Rheumatology Unit, report that 10 out of 13 patients (77%) who had a rheumatic disease and COVID-19, and subsequently underwent SARS-CoV-2 antibody testing, had detectable antibodies.
-
Patients with Rheumatic Disease Are at High Risk of COVID-19 Complications
At the American College of Rheumatology Convergence 2020, Kristin D'Silva, MD, a rheumatology fellow at Massachusetts General Hospital, reported that COVID-19 patients with rheumatic disease are at high risk of mechanical ventilation.
-
Risk of Respiratory Failure Tripled in COVID-19 Patients with Existing Rheumatic Disease
Massachusetts General Hospital clinicians find that patients with rheumatic disease who develop COVID-19 need close monitoring.
Rheumatology
The Rheumatology Unit at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.
